Gestational dietary protein is associated with sex specific decrease in blood flow, fetal heart growth and post-natal

Juan H Hernandez-Medrano1, Katrina J Copping2, Andrew Hoare3

  • 1School of Veterinary and Medical Science, University of Nottingham, Sutton Bonington, United Kingdom.

Plos One
|April 28, 2015
PubMed

Insights

Male fetuses show increased uterine artery blood flow early in pregnancy. Maternal protein restriction impacts fetal cardiovascular development differently based on sex, affecting hemodynamics and long-term blood pressure.

Area of Science:

  • Reproductive physiology
  • Fetal development
  • Maternal-fetal medicine

Background:

  • Adverse pregnancy outcomes are more common in male fetuses.
  • Sex-specific differences in feto-placental perfusion are linked to placental insufficiency and fetal growth restriction.

Purpose of the Study:

  • To investigate sex-specific differences in placental perfusion.
  • To correlate these perfusion changes with fetal growth.
  • To examine the impact of maternal diet on uterine hemodynamics and fetal development.

Main Methods:

  • Utilized Doppler ultrasonography to assess median uterine artery (MUA) blood flow and fetal development monthly from 36 days post conception (dpc) to term.
  • Analyzed excised fetuses and placentae at 98 dpc (n=48).
  • Investigated effects of varying dietary crude protein (CP) levels (7-18%) from 60 days prior to conception up to 98 dpc in heifers.

Main Results:

  • MUA blood flow to male fetuses increased in early pregnancy, correlating with enhanced fetal growth.
  • Protein restriction prior to 23 dpc increased MUA diameter and velocity indices in late pregnancy.
  • Maternal diet influenced fetal cardiovascular development with sex-specific effects, including altered heart weight, heart rate, and later blood pressure.

Conclusions:

  • Observed sex-specific differences in feto-placental Doppler perfusion indices and their response to dietary changes.
  • Maternal diet significantly impacts fetal cardiovascular system development and in utero hemodynamics in a sex-biased manner.
  • This study provides insights into gender-specific circulatory differences during the fetal period and cardiovascular system development.
Abstract

Related Concept Videos

Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
441
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
2.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
499